3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
5
Leukemia, Myeloid, Chronic-Phase
3
Blast Crisis
2
Philadelphia Chromosome
1
Myeloproliferative Disorders
1
Multiple Myeloma
1
Lymphoma, Non-Hodgkin
1
Leukemia, Myeloid, Accelerated Phase
1
Interventions
pembrolizumab
4
Cyclophosphamide
4
Radiotherapy
3
Cisplatin
3
fludarabine
2
Doxorubicin
2
Carboplatin
2
zimberelimab
1
olaparib
1
lenvatinib
1
envafolimab
1
avelumab
1
Thymectomy
1
Taxes
1
Sunitinib
1
Robotic Surgical Procedures
1
Ramucirumab
1
Radiotherapy, Adjuvant
1
Paclitaxel
1
Nivolumab
1
Magnetic Resonance Spectroscopy
1
Etoposide
1
Drug Therapy
1
Chemoradiotherapy
1
Cetuximab
1
AP 1903 reagent
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Thymoma
×
bosutinib
×
1 year
×
Clear all
No trials found.